Brief: Amicus Therapeutics Announces European Commission Approval For Pombiliti™ In Patients With Late-Onset Pompe Disease

Amicus Therapeutics

27/03/2023 12:25

March 27 (Reuters) - Amicus Therapeutics Inc  FOLD.O :
    * AMICUS THERAPEUTICS ANNOUNCES EUROPEAN COMMISSION APPROVAL
FOR
POMBILITI™ IN PATIENTS WITH LATE-ONSET POMPE DISEASE
    * AMICUS THERAPEUTICS INC - CHMP OPINION FOR MIGLUSTAT, ORAL
ENZYME STABILIZER COMPONENT OF AT-GAA, ON-TRACK FOR 2Q 2023

Source text for Eikon:  ID:nGNXFRbWG 
Further company coverage:  FOLD.O 

 ((Reuters.Briefs@thomsonreuters.com;))